HomeEach chapter underwent extensive review; all chapters were reviewed by the Editor, at least one Associate Editor and one other chapter author before a 2-day meeting of all authors held on September 23 and 24, 2021. At this meeting, each chapter was presented by authors, followed by the reviewers’ comments, after which all authors provided input. Specific sessions during this meeting were devoted to review of evidence and discussion of recommendations for Directly Observed Treatment (included in Chapter 5: Treatment of TB Disease) and review of evidence for effect of treatment on contagiousness and TB transmission with recommendations for discontinuation of respiratory isolation (included in Appendix B – De-Isolation Review and Recommendations). Consensus was reached on recommendations for these two topics during this meeting.
Following the all-authors’ meeting, each chapter was revised by chapter authors and then reviewed by the Editor. Subsequent revised versions were sent for external reviews by experts in the topic (selected by the Editor and/or the chapter authors). Selected chapters were reviewed by representatives of AMMI Canada, and all chapters were independently reviewed by members of the CRGC. Each reviewer provided a detailed review and suggestions. Authors responded to these reviews, and all reviews, and subsequent revisions were reviewed by the Editor. Upon acceptance, the CRGC recommended approval of the guideline to the CTS Executive Committee.
Switch To: Français